Siemens Healthineers AG
Siemens Healthineers AG (SHL.DE) Stock Overview
Explore Siemens Healthineers AG’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
51.7B
P/E Ratio
24.89
EPS (TTM)
$1.86
ROE
0.11%
SHL.DE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Siemens Healthineers AG (SHL.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 43.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $55.55.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.89 and a market capitalization of 51.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Bernhard Montag
72,000
Henkestrasse 127, Forchheim
2018